1,216 results on '"Ulrich, M."'
Search Results
2. Multimodal Therapy Approaches for NUT Carcinoma by Dual Combination of Oncolytic Virus Talimogene Laherparepvec with Small Molecule Inhibitors
3. Kullmann/Pfister/Stöhr/Spindler (Hrsg.), Produzentenhaftung
4. The AI ethics of digital COVID-19 diagnosis and their legal, medical, technological, and operational managerial implications
5. Key Contributors to Signal Generation in Frequency Mixing Magnetic Detection (FMMD): An In Silico Study
6. In Vitro Sensitivity of Neuroendocrine Neoplasms to an Armed Oncolytic Measles Vaccine Virus
7. Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma
8. Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3
9. Functional host-specific adaptation of the intestinal microbiome in hominids
10. NUT carcinoma in pediatric patients: Characteristics, therapeutic regimens, and outcomes of 11 cases registered with the German Registry for Rare Pediatric Tumors (STEP)
11. SEGMENTATION OF INDUSTRIAL BURNER FLAMES: A COMPARATIVE STUDY FROM TRADITIONAL IMAGE PROCESSING TO MACHINE AND DEEP LEARNING
12. Unnatural Endotype B PPAPs as Novel Compounds with Activity against Mycobacterium tuberculosis
13. Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology
14. Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication
15. C. Analytischer Teil
16. D. Zusammenfassende Bewertung
17. Gesetz zur Gewährleistung selbstbestimmten Sterbens und zur Suizidprävention
18. P450 Monooxygenase System
19. Quellenverzeichnis
20. Literaturverzeichnis
21. Titelei/Inhaltsverzeichnis
22. B. Deskriptiver Teil
23. A. Anlass, Ziel und Gegenstand des Gutachtens
24. Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience
25. Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities
26. Diffeomorphic Surface Modeling for MRI-Based Characterization of Gastric Anatomy and Motility
27. Gesundheitsschutz durch Umweltrecht am Beispiel der Luftreinhalteplanung
28. A. Stammzellregulierung in Deutschland: verfassungs- und stammzellrechtliche Handlungsbedarfe
29. Quellenverzeichnis
30. Titelei/Inhaltsverzeichnis
31. B. Translation von Ergebnissen der Stammzellforschung in medizinische Anwendungen – Rechtslage und Regelungsbedarf
32. P450 Monooxygenase System
33. Literaturverzeichnis
34. Novel Biological Therapies with Direct Application to the Peritoneal Cavity
35. COMBINING HOLOLENS WITH INSTANT-NERFS: ADVANCED REAL-TIME 3D MOBILE MAPPING
36. Abstract CT119: A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with FGFR3 alterations (trial in progress)
37. IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
38. Supplementary Figure 1 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
39. Supplementary Table 1 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
40. Supplementary Figure Legend from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
41. Supplementary Figure 2 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
42. Supplementary Figure 4 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
43. Supplementary Figure 4 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
44. Supplementary Table 1 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
45. Supplementary Figure 3 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
46. Supplementary Figure 2 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
47. Data from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
48. Supplementary Figure 1 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
49. Supplementary Figure 3 from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
50. Supplementary Figure Legend from Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.